News Splash 1
“First they ignore you, then they laugh at you, then they fight you, then you win.” – Mahatma Gandhi
Similar Posts
NIMH-Harvard study: 74% children prescribed SSRI suffer adverse effects
NIMH-Harvard study: 74% children prescribed SSRI suffer adverse effects Fri, 22 Aug 2003 A report in the Journal of Child and Adolescent Psychopharmacology (abstract below) Dr. Timothy Wilens, Dr. Joseph Biederman, et al, child psychiatrists at Harvard’s teaching hospital, Massachusetts General, found that 22% of children and adolescents who had…
Risperdal Linked to Stroke; Zyprexa linked to Diabetes
Risperdal Linked to Stroke; Zyprexa linked to Diabetes Fri, 11 Apr 2003 Two highly promoted, best selling neuroleptic drugs (also called, antipsychotics) are linked to life-threatening drug-induced conditions. The Boston Globe reports (below) that elderly people who are prescribed Risperdal are at increased risk of stroke. The manufacturer, Johnson and…
Military proposes serious relaxation of IND regulations
Military proposes serious relaxation of IND regulations Tue, 28 Jan 2003 We are rapidly approaching The Brave New World. FDA bureaucrats are attempting to institutionalize a double standard in human experimentaion by resorting to a strategy of doublespeak. A Department of Defense memo states: “DoD should continue to conduct trials…
Lilly Shares Fall After BMJ Report About Prozac Documents – NYT
Lilly Shares Fall After BMJ Report About Prozac Documents – NYT Sat, 1 Jan 2005 The New York Times reports that Jeanne Lenzer’s investigative report in the current (Jan 1) British Medical Journal, citing Eli Lilly secret documents showing that company officials knew since 1988 that Prozac increased violent and…
Article
Letter from David Healy, MD to Peter J. Pitts Executive Summary of suicidal evidence not addressed by FDA In the light of Traci Johnson’s death on February 7th 2004, will FDA obtain Pfizer’s entire folder on the 1982 Hindmarch study in which healthy volunteers were given Zoloft, and make a…
Pfizer Acknowledges It Failed to Reveal Celebrex cardiac risk found in 1999 trial
Pfizer Acknowledges It Failed to Reveal Celebrex cardiac risk found in 1999 trial Tue, 1 Feb 2005 The New York Times reports: “Responding to the Vioxx withdrawal [Sept. 30, 2004], Pfizer said in October that no completed study had ever shown any increased heart risks related to Celebrex. Then, in…